Navigating the Lab Data Marketplace
Speaker:
Michael Astion, MD, PhD, Geoffrey Baird MD, PhD, Bridget Wegner, MS, MLS(ASCP), Creator and Co-Founder, PLUGS, Seattle Children’s Hospital, Professor, Department of Laboratory Medicine and Pathology, University of Washington, Professor and Chair, Department of Laboratory Medicine and Pathology, University of Washington, Director of Partnerships, Clarivate
Contact Hours:
1.0
Date:
April 08, 2025 - April 30, 2026
Description:
Using every academic trick in the book, including the invocation of “my mother medicine” and an analogy to flying cars, Drs. Mike Astion and Geoff Baird interview Bridget Wegner, Director of Partnerships at Clarivate about the commercialization of lab data. Bridget, a seasoned lab and IT professional, emphasizes the importance of lab data in advancing drug development and making drugs more available to patients with rare diseases. The conversation covers the benefits, and risks of selling lab data; privacy and security concerns; and the practicalities of engaging with Clarivate.
Learning Objectives:
- Define real-world data (RWD) and explain its significance in pharmaceutical research and drug development.
- Analyze the ethical, privacy, and security considerations involved in the commercialization of laboratory data.
- Evaluate the potential benefits and risks of selling de-identified clinical laboratory data to third parties, such as pharmaceutical companies.